WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020

Non-dilutive financing to fund continued growth including accelerating sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patients Company financials will now be filed on September 30, 2020 with management-hosted earnings call on October 1, 2020 at 10 a.m. EST — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensedContinue reading “WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020”

Delta 9 Reports Financials for Q2 2020

— DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month and six-month period ending June 30, 2020. Financial Highlights for the three-month period ending June 30, 2020 Net revenue of $13.0 million for the second quarter of 2020, an increaseContinue reading “Delta 9 Reports Financials for Q2 2020”

Alcanna Inc. Announces Timing of Second Quarter 2020 Earnings Release

— Alcanna Inc. (the “Company” or “Alcanna”) (TSX: CLIQ) today announced that it plans to release its second quarter 2020 financial results after markets close on August 19, 2020.   Management will conduct a conference call on August 20, 2020 at 12:00p.m. ET (10:00a.m. MT) to discuss its second quarter operating and financial results. To participate,Continue reading “Alcanna Inc. Announces Timing of Second Quarter 2020 Earnings Release”

Cresco Labs to Report Second Quarter 2020 Financial Results on August 20th, 2020

)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report its financial results for the second quarter ended June 30th, 2020 on Thursday, August 20th, 2020 after market close. The Company will host a conference call and webcast toContinue reading “Cresco Labs to Report Second Quarter 2020 Financial Results on August 20th, 2020”

Trulieve Cannabis Corp. Announces Release Date, Conference Call and Webcast for the Second Quarter of 2020

D All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 4364705. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until August 19, 2020. To access the archived conference call, please dial 1-855-859-2056 and enter the encore codeContinue reading “Trulieve Cannabis Corp. Announces Release Date, Conference Call and Webcast for the Second Quarter of 2020”

Curaleaf to Report Second Quarter Financial and Operational Results

— Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today announced that it will report its financial and operating results for the second quarter ended June 30, 2020 after market close on August 17, 2020. Management will host a conference call and audio webcast that evening at 5:00 p.m. ET consistingContinue reading “Curaleaf to Report Second Quarter Financial and Operational Results”

The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2020

– The Valens Company Inc. (formerly Valens GroWorks Corp.) (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce it will issue its second quarter 2020 financial results, for the period ended May 31, 2020, on Wednesday, July 15, 2020, after markets close. CONFERENCE CALLContinue reading “The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2020”

MediPharm Labs Sets Date to Release Second Quarter 2020 Financial Results

— MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release its second quarter financial results for the three and six month period ended June 30, 2020 before markets open on Thursday,Continue reading “MediPharm Labs Sets Date to Release Second Quarter 2020 Financial Results”